Die Dermapharm Holding mit Sitz in Grünwald stellt dermatologische und allergologische Arzneimittel her. Das mittelständische Unternehmen wurde 1991 gegründet und ging im Februar 2018 an den Prime Standard der Frankfurter Börse.

COMPANY

Dermapharm Holding

INVESTOR TERMSHEET

#BGFL app

#BGFL Publisher

DMP

Dermapharm Holding

#BGFL Mood: Neutral · #BGFL-Indicator: Hold · Review date: -

LEI: 5299009F0KNZINQQQK37

SECTOR: Gesundheit SUB-SECTOR: Pharma

NAME

Dermapharm Holding

WKN

A2GS5D

ISIN

DE000A2GS5D8

TICKER

DMP

INDEX

SDAX

EXCHANGE

Xetra

BUY SELL

Made with ❤ von BGFL

#BGFL

Newswire

Ratings

#BGFL-nes Dermapharm Holding: boersengefluester.de (BGFL) regularly writes extensive editorial articles for most of the companies in our database - especially those in the special stocks sector. Here we show you a list of the most recent articles by BGFL on the selected share.

07.07.2022	Dermapharm Holding: Wird da mehr draus?
25.10.2021	Dermapharm Holding: Zurück auf Rekordhoch
13.04.2021	Dermapharm Holding: Was für ein Ausblick
16.11.2020	Dermapharm Holding: Schafft der Kurs es diesmal?
19.05.2020	Dermapharm Holding: Auf dem Weg zum Verdoppler

Newswire Dermapharm Holding: Official company news is an enormously important source of information for investors - especially if it is particularly price-sensitive and therefore subject to ad hoc disclosure. Here we show the reports provided by the IR portal EQS News on companies from the BGFL coverage universe.

14.11.2024	EQS-News: Dermapharm Holding SE posts strong results for Q3 2024, Arkopharma (France) back above prior-year EBITDA levels for first time
27.08.2024	EQS-News: Dermapharm Holding SE: High-margin existing business in branded pharmaceuticals segment drives organic growth at German and international companies
14.08.2024	EQS-News: Sustained organic growth in high-margin existing branded pharmaceutical business
27.06.2024	EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
15.05.2024	EQS-News: Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy

Resaerch for Dermapharm Holding: Independent research is hard to find, especially in the speciality stocks sector. However, there are a number of firms that regularly produce meaningful analyses of the companies they cover. As a rule, this is paid research - but the analyses are definitely worth reading.

No data

The #BGFL Coverage App Gallery

Visualisation of financial information has been one of boersengefluester.de's (BGFL) favourite disciplines from the very beginning. For this reason, we also put a lot of effort into maintaining our own database and have developed numerous analysis tools and key figure tables on this basis.

Corporate Name Change

Financial Calendar

Interviews, Quotes, Analyses

IR-Quick Check

Annual Reports

Does news drive share prices or does the chain of effects run the other way round - as is often assumed? Well, at boersengefluester.de we offer you all kinds of ways to follow daily stock market events. Take a look at our apps on the subject of news.

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.

Dermapharm Holding

Quick Links

Network

Partner

Contact

Dermapharm Holding

Would you like to see fewer adverts? Simply register for a user account. Registration is free and significantly reduces the number of adverts.

Quick Links

Network

Partner

Contact